Tyson (TSN) Offering Possible 10.86% Return Over the Next 24 Calendar Days

Tyson's most recent trend suggests a bullish bias. One trading opportunity on Tyson is a Bull Put Spread using a strike $72.50 short put and a strike $67.50 long put offers a potential 10.86% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $72.50 by expiration. The full premium credit of $0.49 would be kept by the premium seller. The risk of $4.51 would be incurred if the stock dropped below the $67.50 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Tyson is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Tyson is bullish.

The RSI indicator is above 80 which suggests that the stock is in overbought territory.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Tyson

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tyson Foods, Inc. Investors to Secure Counsel Before Important April 5 Deadline in Securities Class Action – TSN
Sun, 21 Mar 2021 19:46:00 +0000
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tyson Foods, Inc. (NYSE: TSN) between March 13, 2020 and December 15, 2020, both dates inclusive (the “Class Period”), of the important April 5, 2021 lead plaintiff deadline in the securities class action first filed by the firm.

SHAREHOLDER DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tyson Foods, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Fri, 19 Mar 2021 04:40:00 +0000
LOS ANGELES, CA / ACCESSWIRE / March 19, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tyson Foods, Inc. (“Tyson” or “the Company”) (NYSE:TSN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.

ROSEN, A LEADING LAW FIRM, Encourages Tyson Foods, Inc. Investors to Secure Counsel Before Important April 5 Deadline in Securities Class Action – TSN
Thu, 18 Mar 2021 23:00:00 +0000
New York, New York–(Newsfile Corp. – March 18, 2021) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tyson Foods, Inc. (NYSE: TSN) between March 13, 2020 and December 15, 2020, both dates inclusive (the “Class Period”), of the important April 5, 2021 lead plaintiff deadline in the securities class action first filed by the firm.SO WHAT: If you purchased Tyson securities during the Class …

Germany’s ‘Sausage King’ Is Said to Explore $5 Billion Sale
Thu, 18 Mar 2021 20:11:33 +0000
(Bloomberg) — Billionaire Clemens Toennies is exploring a sale of Germany’s largest meat processor, almost a year after his namesake company was embroiled in a nationwide scandal due to a huge coronavirus outbreak at one of his packing plants.Toennies Holding ApS & Co.’s family owners are preparing a sale process for the 50-year-old company, according to people familiar with the matter. The business may be valued at as much as 4 billion euros ($4.8 billion) in an auction, they said, asking not to be identified because the discussions are private.The company could start talks with potential bidders as soon as the next few weeks, the people said. Toennies plans to gauge interest from a narrow group of industry peers including Tyson Foods Inc., Brazil’s JBS SA and WH Group Ltd., the Chinese company that bought Smithfield Foods Inc. in 2013, the people said.No final decisions have been made, and there’s no certainty the deliberations will lead to a transaction, the people said. Representatives for Toennies, Tyson and JBS declined to comment. A spokesperson for Hong Kong-listed WH Group didn’t immediately respond to emailed queries outside regular business hours.Clemens Toennies, chief executive officer of the German group, is often described as a brash billionaire. He turned into a public villain when one of his meatpacking plants was ordered to shut after more than 1,500 workers tested positive for Covid-19.The outbreak, Germany’s biggest at the time, led to criticism of the company’s use of low-paid contract workers from eastern Europe and claims that their working environment failed to prevent the spread of the virus. Toennies has since launched a number of initiatives to try to regain the public’s trust.The family’s fortunes are rooted in the industrialization of Germany’s meat production. Clemens Toennies, who owns about 45% of the company, and his nephew Robert, who holds 50%, will both likely sell their stakes in any deal, the people said. The elder Toennies has long been in the public eye, earning the nickname of “the sausage king,” and was previously chairman of German soccer team Schalke 04.Toennies has about 16,500 employees and generated about 7.3 billion euros of revenue in 2019, according to its website. It’s the biggest meat processor in Germany, running slaughterhouses for pigs and cattle. It also makes Boeklunder brand cocktail sausages, Koenecke bockwurst and Wikinger hot dogs.(Updates with JBS response in the fourth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyson Foods, Inc. – TSN
Thu, 18 Mar 2021 20:03:00 +0000
Pomerantz LLP is investigating claims on behalf of investors of Tyson Foods, Inc. (“Tyson” or the “Company”) (NYSE: TSN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.